SITE MAP | SEARCH | ENGLISH Last paid: 73.00 Lowest today: 72.00 Highest today: 73.75 HOME THE MEDIVIR GROUP RESEARCH AND DEVELOPMENT DRUG INVESTOR PRESS ROOM CAREER PLUG Research and Development At Medivir, we work in all phases of pharmaceutical research, partly with projects that we run under our own auspices and partly in projects together with various partners. The focus of research and development is on infectious diseases, osteoarthritis and oncology. Read more about our research and development Read more about our project portfolio Drug Within the Medivir Group, we have several prescription drugs for the treatment of diseases in a number of different therapy areas. Our goal is to provide innovative drugs for improves people's health and quality of life. Read more about our medicines Visit our Press Room if you want to read the press releases we send out or see what the media writes about Medivir. Press room Medivir strengthens its clinical pipeline by signing an agreement to acquire a portfolio of oncology programs in the clinical phase "This transaction is an important step in the transformation of Medivir, where the strategy is to broaden our pipeline with programs in the late clinical phase and shift the focus from early research to clinical development." NIKLAS PRAGER, CEO Read more Upcoming activities Jan 9 Medivir participates in The JP Morgan Annual Healthcare Conference in San Francisco Feb 15 Medivir participates in The 26th Conference of the Asian Pacific Association for the Study of the Liver (APASL) in China All upcoming activities Annual Report 2015 read here PAGE UPDATED NO LATER THAN 11 NOVEMBER 2016